CANOPY BIOSCIENCES
Canopy Biosciences is biotechnological company that provides products and services for gene editing and personalized medicine. The gene editing technology is called TUNR and targets translation elongation by inserting polyA tracks into targeted coding regions of the genome. This change then decreases the levels of mRNA transcribed from the gene and therefore suppresses protein expression. It was initially developed by Professor Sergej Djuranovic at Washington University School of Medicine and Professor Rachel Green from Johns Hopkins University. Canopy Biosciences was formed in 2016 and is headquartered in Saint Louis, Missouri.
CANOPY BIOSCIENCES
Industry:
Biopharma Biotechnology Health Care Life Science
Founded:
2016-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Website Url:
http://www.canopybiosciences.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Content Delivery Network Wordpress Plugins
Similar Organizations
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-12-06 | Core Diagnostics | Core Diagnostics acquired by Canopy Biosciences | N/A |
2019-04-29 | Zellkraftwerk | Zellkraftwerk acquired by Canopy Biosciences | N/A |
Investors List
Ampersand Capital Partners
Ampersand Capital Partners investment in Venture Round - Canopy Biosciences
Pinpoint Holdings
Pinpoint Holdings investment in Series A - Canopy Biosciences
Missouri Technology Corporation
Missouri Technology Corporation investment in Series A - Canopy Biosciences
Greenleaf Seed Fund
Greenleaf Seed Fund investment in Series A - Canopy Biosciences
Kingdom Capital
Kingdom Capital investment in Series A - Canopy Biosciences
Archangels
Archangels investment in Series A - Canopy Biosciences
BioGenerator
BioGenerator investment in Series A - Canopy Biosciences
Ampersand Capital Partners
Ampersand Capital Partners investment in Seed Round - Canopy Biosciences
Official Site Inspections
http://www.canopybiosciences.com Semrush global rank: 3.85 M Semrush visits lastest month: 3.39 K
- Host name: 25.16.154.104.bc.googleusercontent.com
- IP address: 104.154.16.25
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York